Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.

Illumina and Celgene could exit genome researcher Human Longevity in a reverse merger while Openly raised $75m from investors including Advance Venture Partners and Gradient Ventures.

Gene-sequencing technology producer Axbio raised nearly $100m in a round co-led by AstraZeneca-CICC Investment Fund while Eli Lilly helped Forbion Growth Opportunities Fund II to a $504m first close.

Ascenion and Goethe University Frankfurt are among the initiators of Carma Fund I, which will help start up and fund early life science projects.

Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.

Cancer biopsy developer Elypta raised $21m in a round led by Bonnier Ventures while Evli Bank led cryptocurrency arbitrage platform Mosdex's $20m series A.

Google and Times Group helped boost ShareChat’s latest round to $520m while Animoca Brands has acquired a majority stake in portfolio company TinyTap for $38.9m.

Educational Testing Service was part of a $225m round for digital higher education provider UpGrad while SoftBank helped recruitment software provider Fountain extend its series C to $185m.

Oliver Keown, Jotthe Kannappan and Vivian de Ruijter of Intuitive Ventures joined the Global Venturing Review podcast to discuss the future of minimally invasive care.

Qualcomm bought portfolio company Cellwize for $350m while Northrop Grumman took part in a $135m round for radar technology producer Echodyne.